For instance, analyses from German and Canadian SSc registries have indicated that anti‐SSA seropositivity confers approximately 2–3‐fold higher odds of developing interstitial lung disease (ILD) [8, 9]. This evidence concerns the gene TRIM21 and systemic sclerosis.